| Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions B Doshi, SR Athans, A Woloszynska Oncogenesis 12 (1), 44, 2023 | 7 | 2023 |
| STAG2 expression is associated with adverse survival outcomes and regulates cell phenotype in muscle-invasive bladder cancer SR Athans, N Krishnan, S Ramakrishnan, E Cortes Gomez, ... Cancer research communications 2 (10), 1129-1143, 2022 | 4 | 2022 |
| Abstract PR007: Identifying targeted therapies for muscle invasive bladder cancer via STAG2 expression SR Athans, H Withers, Z Kazmierczak, K Gurova, A Woloszynska Clinical Cancer Research 30 (10_Supplement), PR007-PR007, 2024 | | 2024 |
| Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer S Ramakrishnan, E Cortes-Gomez, SR Athans, KM Attwood, SR Rosario, ... Genome Medicine 16 (1), 52, 2024 | | 2024 |
| STAG2 acts as a transcriptional repressor and promotes invasion of muscle invasive bladder cancer cells SR Athans, N Krishnan, S Ramakrishnan, EC Gomez, S Lage-Vickers, ... Cancer Research 82 (12_Supplement), 786-786, 2022 | | 2022 |
